We are live on ! Find out more
CCA

Column Capital Advisors Portfolio holdings

AUM $680M
1-Year Est. Return 15.16%
This Fund
S&P 500
This Quarter Est. Return
+8.57%
1 Year Est. Return
+15.16%
3 Year Est. Return
+20.42%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$603M
AUM Growth
+$119M
Cap. Flow
+$665M
Cap. Flow %
110.3%
Top 10 Hldgs %
64.49%
Holding
863
New
125
Increased
179
Reduced
80
Closed
23

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$269M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$220M
3
VTI icon
Vanguard Total Stock Market ETF
VTI
+$80.3M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$57.3M
5
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$29.1M

Top Sells

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$35.5M
2
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$24.8M
3
DRE
Duke Realty Corp.
DRE
+$11.9M
4
VB icon
Vanguard Small-Cap ETF
VB
+$9.64M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$6.91M

Sector Composition

Rank Sector Weight
1 Real Estate 3.25%
2 Technology 2.94%
3 Healthcare 2.82%
4 Financials 1.59%
5 Consumer Discretionary 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVAX icon
776
Novavax
NVAX
$1.27B
$720 ﹤0.01%
70
+1
+1% +$18
BH.A icon
777
Biglari Holdings Class A
BH.A
$1.18B
$689 ﹤0.01%
1
– –
WAT icon
778
Waters Corp
WAT
$36.4B
$685 ﹤0.01%
2
– –
CDE icon
779
Coeur Mining
CDE
$15.9B
$672 ﹤0.01%
200
– –
SNDL icon
780
Sundial Growers
SNDL
$331M
$669 ﹤0.01%
+320
New +$761
HY icon
781
Hyster-Yale Materials Handling
HY
$589M
$658 ﹤0.01%
26
– –
CRL icon
782
Charles River Laboratories
CRL
$10.9B
$654 ﹤0.01%
+3
New +$655
TDS icon
783
Telephone and Data Systems
TDS
$3.85B
$650 ﹤0.01%
+62
New +$767
EXEL icon
784
Exelixis
EXEL
$14.1B
$642 ﹤0.01%
+40
New +$652
PLTR icon
785
Palantir
PLTR
$313B
$642 ﹤0.01%
100
-10
-9% -$76
ATAI icon
786
AtaiBeckley Inc
ATAI
$2.65B
$638 ﹤0.01%
+240
New +$729
TWLO icon
787
Twilio
TWLO
$29.7B
$636 ﹤0.01%
13
-22
-63% -$1.25K
HIVE
788
HIVE Digital Technologies
HIVE
$789M
$576 ﹤0.01%
400
– –
SLVM icon
789
Sylvamo
SLVM
$1.51B
$534 ﹤0.01%
11
– –
REZI icon
790
Resideo Technologies
REZI
$5.3B
$526 ﹤0.01%
32
– –
SOPH icon
791
SOPHiA GENETICS
SOPH
$478M
$515 ﹤0.01%
250
– –
CZR icon
792
Caesars Entertainment
CZR
$6.12B
$499 ﹤0.01%
+12
New +$534
VNT icon
793
Vontier
VNT
$4.43B
$483 ﹤0.01%
25
– –
RIGL icon
794
Rigel Pharmaceuticals
RIGL
$705M
$465 ﹤0.01%
+31
New +$284
BAX icon
795
Baxter International
BAX
$12B
$459 ﹤0.01%
9
– –
DXC icon
796
DXC Technology
DXC
$1.7B
$451 ﹤0.01%
17
– –
BKR icon
797
Baker Hughes
BKR
$60.3B
$443 ﹤0.01%
+15
New +$414
ALB icon
798
Albemarle
ALB
$13.6B
$434 ﹤0.01%
+2
New +$533
CEG icon
799
Constellation Energy
CEG
$97.6B
$431 ﹤0.01%
+5
New +$450
MRO
800
DELISTED
Marathon Oil Corporation
MRO
$406 ﹤0.01%
+15
New +$435
30 31
32
33 34

Similar funds

FMAEN1
Fund Management at Engine No 1 San Francisco, California $653M AUM 30.58% 1-Year Est. Return
DBT
Dubuque Bank & Trust Dubuque, Iowa $748M AUM 12.31% 1-Year Est. Return
WWM
Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return
FDCC
Foster Dykema Cabot & Co Waltham, Massachusetts $827M AUM 18.87% 1-Year Est. Return
FBA
Front Barnett Associates Chicago, Illinois $833M AUM 23.51% 1-Year Est. Return
RWA
Ropes Wealth Advisors Boston, Massachusetts $515M AUM 21.76% 1-Year Est. Return
MAM
Mastrapasqua Asset Management Nashville, Tennessee $853M AUM 37.36% 1-Year Est. Return
IWP
Icon Wealth Partners Houston, Texas $880M AUM

Column Capital Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Column Capital Advisors held 863 positions worth $603M, up 25% from $484M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Column Capital Advisors deployed $665M of net new capital in Q4 2022, opening 125 new positions and adding to 179 existing holdings. Its largest new stake was Moderna: 117,121 shares worth $119K.

By sector, the portfolio is most concentrated in Real Estate at 3.3% of assets, up from 2.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Russell 1000 ETF, an estimated $35.5M trimmed.

  • Column Capital Advisors's largest Q4 2022 buy was Moderna: 117,121 shares worth $119K.
  • Column Capital Advisors added most to Eli Lilly in Q4 2022, an estimated $269M increase.
  • Column Capital Advisors's biggest Q4 2022 reduction was iShares Russell 1000 ETF, cutting an estimated $35.5M.
  • Column Capital Advisors fully exited Duke Realty Corp. in Q4 2022, selling an estimated $11.9M.
  • Column Capital Advisors's ten largest holdings make up 64% of its $603M portfolio in Q4 2022.
  • Column Capital Advisors opened 125 new positions and closed 23 in Q4 2022.
  • Column Capital Advisors's portfolio value rose 25% quarter-over-quarter to $603M.

Based on Column Capital Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.